Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20562526 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Conditions: Carcinoma, Intraductal, Noninfiltrating;   DCIS;   Ductal Carcinoma In Situ
Interventions: Drug: Chloroquine Standard Dose (500mg/week);   Drug: Chloroquine Low Dose (250mg/week);   Procedure: Breast Biopsy

Indicates status has not been verified in more than two years